Protective effect of black seed oil from Nigella sativa against murine cytomegalovirus infection

International Journal of Immunopharmacology

Volumn 22, Issue 9, 2000, Pages 729-740

  Salem, Mohamed Labib ^a   Hossain, Mohammad Sohrab ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Black seed oil; Cytomegalovirus; Cytotoxic T lymphocytes; IFN ; Macrophages; Nigella sativa; NK cells

Indexed keywords

ANTIVIRUS AGENT; GAMMA INTERFERON; NIGELLA SATIVA EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; VIRUS LOAD;

ANIMALS; ANTIVIRAL AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS INFECTIONS; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; FLOW CYTOMETRY; INTERFERON TYPE II; KILLER CELLS, NATURAL; LIVER; MACROPHAGES; MICE; MICE, INBRED BALB C; PLANT OILS; PLANTS, MEDICINAL; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; VIRAL LOAD;

EID: 0034286955     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(00)00036-9     Document Type: Article

References (42)

1. Chopra R., Nayar S., Chopra I. Glossary of Indian medicinal plants. 1956;175 CSIR, New Delhi, India.
2. Nadkarni K. Crocus sativus, Nigella sativa. Nadkarni K.M. Indian materia medica. 1976;386-411 Popular Prakashan, Bombay, India.
3. Attar-ur-Rahman, Malik S., Cunheng H., Clardy J. Isolation and structure of determination of nigellicine, a novel alkaloid from the seeds of Nigella sativa. Tetrahedron Lett. 26:1985;2759-2762.
4. Haq A., Lobo P., Al-Tufail M., Rama N., Al-Sedairy S. Immunomodulatory effect of Nigella sativa proteins fractionated by ion exchange chromatography. Int. J. Immunopharmacology. 21:1999;283-295.
5. Nagi M., Alam K., Badary O., Al-Shabanah O., Al-Sawaf H., Al-Bekairi A. Thymoquinone protects against carbon tetrachloride hepatotoxicity in mice via an antioxidant mechanism. Biochem. Mol. Biol. Int. 47:1999;153-159.
6. Daba M., Abdel-Rahman M. Hepatoprotective activity of thymoquinone in isolated rat hepatocytes. Toxicol. Lett. 95:1998;23-29.
7. Worthen D., Ghoshen O., Crooks P. The in vitro anti-tumor activity of some crude and purified components of black seed, Nigella sativa L. Anticancer Res. 18:1998;1527-1532.
8. Salomi N., Nair S., Panikkar K. Inhibitory effects of Nigella sativa and Saffron (Crocus sativus) on chemical carcinogenesis in mice. Nutrition Cancer. 16:1991;67-72.
9. Salomi N., Nair S., Jayawardhanan K., Varghese D., Panikkar K. Anti-tumor principles from Nigella sativa seeds. Cancer Lett. 63:1992;41-46.
10. Akhtar M., Riffat S. Field trial of Saussurea lappa roots against nematodes and Nigella sativa seeds against cestodes in children. J. Pakistan Med. Assoc. 41:1991;185-187.
11. Agarwal R., Kharya M., Shrivastava R. Antimicrobial and anthelmintic activities of the essential oil of Nigella sativa. Linn. Ind. J. Exp. Biol. 17:1979;1264-1265.
12. Saxena A., Vyas K. Antimicrobial activity of seeds of some ethnopharmacinal plants. J. Econ. Taxon. Botany. 8:1986;291-299.
13. Hanafy M., Hatem M. Studies on the antimicrobial activity of Nigella sativa seed (black cumin). J. Ethnopharmacol. 34:1991;275-278.
14. Mahfouz M., El-Dakhakhny M., Gemei A., Mossa H. Choleretic action of Nigella sativa L. seeds oil. Egyp. Pharmacol. Bull. 44:1962;225-230.
15. Tennekoon K., Jeevathayaparan S., Kurukulasooriya A., Karunanayake E. Possible hepatotoxicity of Nigella sativa seeds and Dregea volubilis leaves. J. Ethnopharmacol. 31:1991;283-289.
16. Haq A., Abdullatif M., Lobo P., Khabar K., Sheth K., Al-Sedairy S. Nigella sativa: Effect on human lymphocytes and polymorphonuclear leukocyte phagocytic activity. Immunopharmacology. 30:1995;147-155.
17. Reynolds P., Rahija J., Schenkman I., Richter B. Experimental murine cytomegalovirus infection in severe combined immunodeficient mice. Lab. Anim. Sci. 43:1993;291-295.
18. Messerle M., Keil M., Schneider K., Koszinowski H. Characterization of the murine cytomegalovirus genes encoding the major DNA-binding protein and the ICP18.5 homology. Virology. 19:1992;355-363.
19. Smith A., Brennessel J. Cytomegalovirus. Infect. Dis. Clin. North Am. 8:1994;427-438.
20. Lygidakis N.J., Ziras F.A., Kyparidou E., Parissis J., Papadopoulou P., Venetsanou B. Combined immunopharmaceutical therapy of patients with unrespectable pancreatic carcinoma. Hepato-Gasternology. 24:(6):1995;1039-1052.
21. Hossain S., Takimoto H., Hamano S., Yoshida H., Ninomiya T., Minamishima Y., Kimura G., Nomoto K. Protective effects of hochu-ekki-to, a Chinese traditional herbal medicine against murine cytomegalovirus infection. Immunopharmacology. 41:1999;169-181.
22. Kaneko M., Kishihara K., Kawakita T., Nakamura T., Takimoto H., Nomoto K. Suppression of IgE production in mice treated with a traditional Chinese medicine, buzhong-yi-qi-tang (Japanese name: hocho-ekki-to). Immunopharmacology. 36:1997;79-85.
23. Ellis N., Young M., Nikcevich D., Newby M., Plioplys R., Wepsic T. Stimulation of prostaglandin-dependent macrophage suppressor cells by the subcutaneous injection of polyunsaturated fatty acids. Cell Immunol. 102:1986;251-260.
24. Polic B., Jonjic S., Pavic I., Crnkovic I., Zorica I., Hengel H., Lucin P., Koszinowski U. Lack of MHC class I complex expression has no effect on spread and control of cytomegalovirus infection in vivo. J. Gen. Virol. 77:1996;217-225.
25. Nair S., Salomi N., Pankkar K. Modulatory effects of Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in mice. J. Ethnopharmacol. 31:1991;75-83.
26. Trinchieri G. Biology of natural killer cells. Adv. Immunol. 47:1989;187-376.
27. Rolstad B., Seaman W. Natural killer cells and recognition of MHC class I molecules: new perspectives and challenges in immunology. Scand. J. Immunol. 47:1998;412-425.
28. Welsh R., Vargas-Cortes M. Lewis E., McGee D. The natural killer cell. 1992;107-150.
29. Orange J., Wang B., Terhorst C., Biron C. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182:1995;1045-1056.
30. Ciccone E., Viale E., Pende D., Malnati M., Biasson R., et al. Specific lysis of allogenic cells after activation of CD3-lymphocytes in mixed lymphocyte culture. J. Exp. Med. 168:1988;2403-2408.
31. Chadwick B., Miller R. Hybrid resistance in vitro: possible role of both MHC class I and self peptides in determining the level of target cell sensitivity. J. Immunol. 148:1992;2307-2313.
32. Orange J., Biron C. Characterization of early IL-12, IFN-αβ and TNF effects on antiviral state and NK cell responses during cytomegalovirus infection. J. Immunol. 56:1961;4746-4756.
33. Tay H., Welsh M. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J. Virol. 71:1997;267-275.
34. Heise M.T., Virgin H.W. The T cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. J. Virol. 69:1995;904-909.
35. Michelson, S., Interaction of human cytomegalovirus with monocytes-macrophages: a love-hate relationship. Pathol Biol 45, 146-158.
36. Hammano S., Yoshida H., Takimoto H., Sonoda K., Osada K., He X., Minamishima Y., Kimura G., Nomoto K. Role of macrophages in acute murine cytomegalovirus infection. Microbiol. Immunol. 42:1998;607-616.
37. Wu L., Morahan P. Macrophages and other nonspecific defense: role in modulating resistance against herpes simplex virus. Curr. Top. Mircobiol. Immunol. 179:1992;89-110.
38. Schwarz K.B. Oxidative stress during viral infection: a review. Free Rad. Biol. Med. 21:1996;641-649.
39. Ikeda S., Neyts J., de Clercq E. The keys of oxidative stress in acquired immune deficiency syndrome apoptosis. Med. Hopthes. 51:1998;169-173.
40. Mortola E., Okuda M., Ohno K., Watari T., Tsujimoto H., Hasegawa A. Inhibition of apoptosis and virus replication in feline immunodeficiency virus-infected cells by N-acetylcysteine. J. Vet. Med. 60:1998;1187-1193.
41. Kos F., Engleman E. Immune regulation: a critical link between NK cells and CTLs. Immunol. Today. 17:1996;174-176.
42. Welsh R., Karre K., Hansson M., Kunkel L., Kiessling R. Interferon-mediated protection of normal and tumor targets against lysis by mouse natural killer cells. J. Immunol. 126:1981;219-225.